158 related articles for article (PubMed ID: 20844869)
1. Are results from pharmaceutical-company-sponsored studies available to the public?
Dal-Ré R; Pedromingo A; García-Losa M; Lahuerta J; Ortega R
Eur J Clin Pharmacol; 2010 Nov; 66(11):1081-9. PubMed ID: 20844869
[TBL] [Abstract][Full Text] [Related]
2. Criteria for site selection in industry-sponsored clinical trials: a survey among decision-makers in biopharmaceutical companies and clinical research organizations.
Dombernowsky T; Haedersdal M; Lassen U; Thomsen SF
Trials; 2019 Dec; 20(1):708. PubMed ID: 31829234
[TBL] [Abstract][Full Text] [Related]
3. The fate of prospective spine studies registered on www.ClinicalTrials.gov.
Ohnmeiss DD
Spine J; 2015 Mar; 15(3):487-91. PubMed ID: 25315132
[TBL] [Abstract][Full Text] [Related]
4. Sharing of clinical trial data and results reporting practices among large pharmaceutical companies: cross sectional descriptive study and pilot of a tool to improve company practices.
Miller J; Ross JS; Wilenzick M; Mello MM
BMJ; 2019 Jul; 366():l4217. PubMed ID: 31292127
[TBL] [Abstract][Full Text] [Related]
5. Publication bias in the pulmonary/allergy literature: effect of pharmaceutical company sponsorship.
Liss H
Isr Med Assoc J; 2006 Jul; 8(7):451-4. PubMed ID: 16889157
[TBL] [Abstract][Full Text] [Related]
6. Interactions between physicians and the pharmaceutical industry: what does the literature say?
Lexchin J
CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
[TBL] [Abstract][Full Text] [Related]
7. Data sharing from pharmaceutical industry sponsored clinical studies: audit of data availability.
Hopkins AM; Rowland A; Sorich MJ
BMC Med; 2018 Sep; 16(1):165. PubMed ID: 30261889
[TBL] [Abstract][Full Text] [Related]
8. Making available information from studies sponsored by the pharmaceutical industry: some current practices.
O'Kelly M; Julious SA; Pyke S; Day S; Todd S; Seldrup J; Matcham J
Pharm Stat; 2011; 10(1):60-9. PubMed ID: 21275036
[TBL] [Abstract][Full Text] [Related]
9. Plain Language Summaries of Clinical Trial Results: A Preliminary Study to Assess Availability of Easy-to-Understand Summaries and Approaches to Improving Public Engagement.
Penlington M; Silverman H; Vasudevan A; Pavithran P
Pharmaceut Med; 2020 Dec; 34(6):401-406. PubMed ID: 33113147
[TBL] [Abstract][Full Text] [Related]
10. Noncommercial US Funders' Policies on Trial Registration, Access to Summary Results, and Individual Patient Data Availability.
Whitlock EP; Dunham KM; DiGioia K; Lazowick E; Gleason TC; Atkins D
JAMA Netw Open; 2019 Jan; 2(1):e187498. PubMed ID: 30681715
[TBL] [Abstract][Full Text] [Related]
11. Informational content of official pharmaceutical industry web sites about treatments for erectile dysfunction.
Waack KE; Ernst ME; Graber MA
Ann Pharmacother; 2004 Dec; 38(12):2029-34. PubMed ID: 15507499
[TBL] [Abstract][Full Text] [Related]
12. Delays in completion and results reporting of clinical trials under the Paediatric Regulation in the European Union: A cohort study.
Hwang TJ; Tomasi PA; Bourgeois FT
PLoS Med; 2018 Mar; 15(3):e1002520. PubMed ID: 29494592
[TBL] [Abstract][Full Text] [Related]
13. Impact of study outcome on submission and acceptance metrics for peer reviewed medical journals: six year retrospective review of all completed GlaxoSmithKline human drug research studies.
Evoniuk G; Mansi B; DeCastro B; Sykes J
BMJ; 2017 Apr; 357():j1726. PubMed ID: 28432051
[No Abstract] [Full Text] [Related]
14. Clinical trial transparency update: an assessment of the disclosure of results of company-sponsored trials associated with new medicines approved in Europe in 2013.
Deane BR; Sivarajah J
Curr Med Res Opin; 2017 Mar; 33(3):473-478. PubMed ID: 27869482
[TBL] [Abstract][Full Text] [Related]
15. Availability of Clinical Trial Data From Industry-Sponsored Cardiovascular Trials.
Murugiah K; Ritchie JD; Desai NR; Ross JS; Krumholz HM
J Am Heart Assoc; 2016 Apr; 5(4):e003307. PubMed ID: 27098969
[TBL] [Abstract][Full Text] [Related]
16. Industry sponsorship and research outcome.
Lundh A; Sismondo S; Lexchin J; Busuioc OA; Bero L
Cochrane Database Syst Rev; 2012 Dec; 12():MR000033. PubMed ID: 23235689
[TBL] [Abstract][Full Text] [Related]
17. Public availability of results of observational studies evaluating an intervention registered at ClinicalTrials.gov.
Baudart M; Ravaud P; Baron G; Dechartres A; Haneef R; Boutron I
BMC Med; 2016 Jan; 14():7. PubMed ID: 26819213
[TBL] [Abstract][Full Text] [Related]
18. Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials.
Matcham J; Julious S; Pyke S; O'Kelly M; Todd S; Seldrup J; Day S
Pharm Stat; 2011; 10(1):70-3. PubMed ID: 20187020
[TBL] [Abstract][Full Text] [Related]
19. Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis.
Ross JS; Mulvey GK; Hines EM; Nissen SE; Krumholz HM
PLoS Med; 2009 Sep; 6(9):e1000144. PubMed ID: 19901971
[TBL] [Abstract][Full Text] [Related]
20. Comments on 'The potential for bias in the reporting of industry sponsored clinical trials' by Stephen Pyke et al. and 'Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry sponsored clinical trials' by James Matcham et al. Pharmaceutical Statistics.
Campbell MJ
Pharm Stat; 2011; 10(1):80-1. PubMed ID: 21275038
[No Abstract] [Full Text] [Related]
[Next] [New Search]
